Evaluating Radiofrequency Ablation for Treating Papillary Thyroid Microcarcinoma in Adults

What this Trial Is About

This research aims to evaluate the safety and effectiveness of Radiofrequency Ablation RFA for treating Papillary Thyroid Microcarcinoma PTMC, a small, low-risk type of thyroid cancer. The study is observational and collects data from patients who have already agreed to undergo RFA based on their doctors recommendation. The goal is to explore less invasive treatment options compared to traditional thyroid surgery, which carries risks like nerve injury, hormone issues, and scarring. The RFA procedure uses ultrasound guidance to insert an electrode through the skin into the tumor. High-frequency electrical currents generate heat to treat the lesion, offering a minimally invasive alternative to surgery. This study collects information generated before and after RFA treatment to assess outcomes over time. Participants provide access to their medical data related to the RFA treatment and undergo regular sonographic evaluations. Researchers monitor for complete disappearance of the tumor on ultrasound at 12 months and track any complications. The study follows patients over at least a year to understand the treatments safety and long-term effects.

RFA Treatment for Papillary Thyroid Microcarcinoma